IL11 and chronic kidney disease: The discrepancy between the limited efficacy of ω3FA in improving CKD progression in vivo and their effective regulation of IL-11 in vitro raises questions about the mechanisms of ω3FA uptake in renal tissues and their reliance on dietary sources and inflammation.